Epileptic seizures due to pyridoxine deficiency, although rare, are known to occur. They are characterized by untreatable convulsions during childhood. We present the case of an epileptic status resistant to conventional treatment in a 29-year-old woman, with no previous history of epileptic seizures, in the 29th week of pregnancy, who responded to the intravenous administration of pyridoxine. Journal of Perinatology (2009) 29, 252-253; doi:10.1038/jp.2008 Keywords: epileptic seizures; vitamin B6 deficit; pregnancy
Case study
We report the case of a 29-year-old healthy, pregnant woman with an obstetric history of one miscarriage and one premature delivery. She was treated daily with 400 mg of folic acid and 2 mg of vitamin B12 during the first trimester and 80 mg of ferrum sulphate since the 24th week. No other drugs were administrated. She reported a normal diet and she had not smoked or drunk alcohol during the pregnancy.
The patient was referred to the Emergency Service in the 29th week of pregnancy, after suffering several self-limited episodes, 1 min in duration, of intense headache accompanied by absence seizures. In the Emergency Service, she presented three complex partial seizures on the right side of the body, with secondary generalization. Vital signs remained within normal levels and the analysis showed normal kidney function, negative proteinuria, normal hepatic enzymes and a discrete microcytic anemia with normal platelet levels. In the obstetric examination, no pathological findings were noted; the fetus presented normal cardiac activity and adequate biometric parameters for its age.
A computerized cranial tomography was performed, with no signs of acute ischemia, a ventricular system of normal size and morphology, and no signs of expansion suggesting the ausence of intracranial mass. A sample of cerebrospinal liquid was taken, presenting non-xanthochromia, glucose levels of 72 mg (100 ml)
À1 , protein levels of 15.3 mg (100 ml)
À1
(15-40 mg (100 ml) À1 ), 1 white blood cell per mm 3 , and lactate levels of 1.6 mM (1.1-2.4 mM). A magnetic resonance imaging (MRI) of the cranium showed no clinically significant alterations.
Despite treatment with carbamazepine, phenytoin and valproate, she began to have generalized, subintrant seizures, failing to regain consciousness, for which she was transferred to the intensive care unit. She showed vital signs within normal levels, with 96% arterial oxygen saturation.
She continued having generalized seizures, required sedation, orotraqueal intubation and artificial respiration. Despite administration of a high dosage of midazolam by infusion (up to 40 mg (100 ml)
) the seizures continued, so that propofol was added to the treatment at a dosage of 2 mg kg À1 h
. Continuous electroencephalographic monitoring (EEG) was prescribed, which proved persistent seizures. Magnesium sulfate was also administered in initial dose (6 g) and posterior permanent infusion of up to 54 mEq in 24 h.
Owing to the persistence of the seizures, plasma levels of vitamin B6 were measured with results of <9 mM (14-100 mM). After the administration of 300 mg of pyridoxine intravenously, the seizures disappeared. An initial dose of 300 mg per 12 h was administered intravenously for the first 48 h, and was reduced to 300 mg per day in the following days. At 7 days after the initial dose of vitamin B6, its concentration was 79 mM. The valproate and the carbamazepine were withdrawn, and the magnesium infusion was gradually reduced, with no seizures observed in the EEG. At 20 days after the admission, the patient was conscious, orientated and collaborative, with no apparent neurological focality, and the plasmatic concentration of vitamin B6 was 137 mM. The last EEG, previous to discharge, showed an acute activity in the anterior left temporal lobe with no clinical seizures. That is why, even the adequate response to vitamin B6 treatment, she continued treatment with phenytoin and vitamin B6 on discharge.
The patient had a posterior normal control of her pregnancy in the high-risk obstetric unit. Finally, at 34 þ 4 weeks of pregnancy she had a premature rupture of membranes. Labor was inducted with a female newborn of 2160 g, with an Apgar test of 7/9 and umbilical artery and vein pH of 7.25 and 7.20, respectively. The course of the puerperium was normal.
She had several controls in the Neurology Service after the pregnancy, with normal levels of vitamin B6, so that treatment was stopped 3 months after the initial diagnosis of vitamin B6 deficit. She never had more seizures.
Discussion
Convulsions during pregnancy are an amazing problem, especially in cases like that of our patient without a background of neurological pathology. Differential diagnosis is very important to promptly start the adequate treatment with the best results for mother and fetus. The possibility of eclampsia must be ruled out. Our patient did not show signs of high blood pressure and/or proteinuria, or other disorders associated with preeclampsia such as thrombocytopoenia, or the alteration of hepatic enzymes and coagulation factors.
The presence of intracerebral neoplasias was ruled out by the cranial scan and thrombosis of venous cerebral sinuses by cranial MRI. In the differential diagnosis, we included acute viral hepatitis, which was ruled out by the negative serology and the fact that there were no hepatic enzyme disorders. The normal urine levels detected of d-aminolevulinic acid and porphobilinogen excluded the possibility of intermittent acute porphyria.
Convulsive seizures associated with vitamin B6 are a specific form of epilepsy first described in 1954. Symptoms are generalized convulsions a few hours after birth that are resistant to standard anticonvulsive treatment and are controlled by the administration of pyridoxine. In 1978, Lott and et al.
1 studied the brain of a patient with this form of epilepsy, finding a reduction in the neurotransmitter, g-aminobutyric acid, in association with a decrease in white matter.
Its prevalence is estimated at 1 in 400,000-700,000 and an autosomal recessive inheritable gene 2 has been associated. Recently, 3 it has been possible to identify the gene ALDH7A, in the 5q31 zone, associated with many cases of pyridoxine-dependent epilepsy. Numerous mutations of ALDH7A have been described in sufferers, although it is not currently possible to establish genotype-phenotype correlations. The consequence of enzyme deficiency, due to mutations of the gene, is the accumulation of the metabolite P6C, which deactivates pyridoxal phosphate, essential cofactor in the metabolism of many neurotransmitters. The administration of pyridoxine in these patients not only corrects secondary pyridoxal phosphate deficiency but also induces the reduction of P6C and other toxic metabolites.
Some cases have been published 4 in children and in adults presenting hardly controlled convulsions since infancy. SchulzeBonhage et al. 5 published the case of a pregnant woman with Ours is a PRS case because seizures never appeared again with B6 withdrawal. A deficiency of vitamin B6 alone is uncommon. There are, however, instances where diets deficient in the vitamin or chemotherapeutic/fortuitous ingestion of antagonists have led to hypovitaminosis B6 including the tuberculostatic isoniazid or penicillamine used in treatment of patients with Wilson disease. 7 In absence of other causes of vitamin B6 depletion, in our patient the pregnancy seems to be the most probable cause of vitamin decrease because of increased demand. 8 Moreover, the anticonvulsives themselves may contribute to a greater decrease in vitamin B6 levels. 9 Probably it had not been necessary to maintain the treatment with phenytoin in our patient, as we had the cause and the adequate treatment for her problem. However, as our first case, and with the last EEG showing abnormal electric activity (without clinic effects), our neurologist decided to maintain it.
In summary, we recommend to test plasmatic vitamin B6 levels in all patients with convulsions resistant to conventional antiepileptic treatment, even where there is no background of seizures during infancy.
